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Abstract 
Objectives: Toxoplasmosis is caused by Toxoplasma gondii. 50 to 
70% of African are contaminated and 60% to 80% in Togo. This parasitic 
infection involves disorders in immunocompromised persons and pregnant 
women. The purpose of this study is to evaluate the seroprevalence of 
toxoplasmosis and the risk factors of contamination in the Togolese 
population. Methods: Prospective studies from January 2012 to December 
2015 concerned 7076 patients. A survey on the risk factors for Toxoplasma 
gondii contamination has done. The seroprevalence was monitored by 
examining serological antibodies IgG and IgM using ELISA method. 
Sampling of 200 excreta of domestic cats were analyzed by coproscopy 
examinations Results: The average age was 32.61±6.80 years old. The 
seroprevalence of IgM was 2.85%; and for IgG 59.7%. IgG were high in men 
(67.0% vs. 58.6%, p<0.0001); IgM were high in women (2.81% vs. 1.85%, 
p<0.01). In this study, we observed 57.49% immunized subjects. Regarding 
potential risk factors for contamination, the survey revealed that 80.5% of 
subjects consume raw garden produce, 65.4% non-potable and 8.3% 
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undercooked meat. In cats, 20.5% of them excreted oocysts of Toxoplasma 
gondii. Conclusion: The prevalence of the toxoplasmosis was high in the 
Togolese population because the risks factors were variable and the level of 
contamination were high too. The country’s health authorities, especially for 
the pregnant women, should install sensitization and prevention programs on 
the risks of the contamination of toxoplasmosis. The high proportion of the 
young subjects affected constitutes a socio-economical danger for the 
country.  
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Introduction 
Toxoplasmosis is one of the most common parasitic infections in 
humans, caused by an Apicomplexa protozoan: Toxoplasma gondii, a 
ubiquitous parasite of warm-blooded animals. The definitive hosts are felids 
(Dubey, 2008; Angel et al., 2014). It has a very wide variety of intermediates 
hosts and can parasitize all types of cells. Horizontal infection generally 
occurs through the ingestion of raw or undercooked meat that contains cysts 
(encysted bradyzoites), through the ingestion of contaminated food or in 
drinking water with oocysts. The transplacental transmission from mother 
infected occurs during pregnancy (Montoya and Liesenfeld, 2004; Dubey, 
2008 ; Dubey et al., 2012; Hammond-Aryee et al., 2014). 
In the immunocompetent subjects, toxoplasmosis is asymptomatic in 
80% of cases. However, ganglionic affection with fever, lymphadenopathy 
and asthenia can be observed. In immunocompromised patients, 
toxoplasmosis caused life-threatening infections such as encephalitis, 
lethargy, ataxia, coma, pneumonia, chorioretinitis. Encephalitis 
toxoplasmosis is the leading cause of death in patients (Webster, 2001; 
Labalette et al., 2002; Montoya and Liesenfeld, 2004; Dubey and Jones, 
2008). The severity of infections is related to the decrease of T-cells and IFN-
γ. This involves rapidly proliferating of tachyzoites leading to tissue necrosis 
(Labalette et al., 2002; Dubey and Jones, 2008; Montoya and Remington, 
2008).  
Symptoms of infection in pregnant women are rare. However, acute 
infection can lead the lesions of the placenta and induce serious type of 
foetopathies. The consequences of congenital infection are spontaneous 
abortions, stillbirths, premature births and multi-visceral lesions (Pinard et 
al., 2003; Dubey and Jones, 2008; Montoya and Remington, 2008). The 
common abortions in patients with toxoplasmosis can be partially attribute to 
the presence of anti-Cardio-Lipin (A'aiz et al., 2014). The gestational age and 
the rate of trans placental infection are in correlation and an inverse 
relationship has been found between the severity of the lesions or clinical 
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signs and the gestational age at which maternal seroconversion occurs 
(Montoya and Remington, 2008; Bamba et al., 2012).  
In neonates and infants, Toxoplasma gondii infection causes 
congenital malformations (hydrocephalus or microcephaly), chorioretinitis, 
convulsions, intracranial calcification, mental retardation, visual 
disturbances, learning difficulties (Dubey and Jones, 2008; Uttah et al., 
2013). Toxoplasmosis in intermediate hosts has been associated with the 
development of neurological disorders (Fond et al., 2012; Angel et al., 2014).  
Toxoplasmosis diagnosis is mainly based on the presence of anti-
Toxoplasma gondii antibodies (IgG and IgM) in the serum. Several tests can 
be used as dye test, immuno fluorescent study test, latex agglutination enzyme 
linked immunosorbent assay (ELISA) (Hamad and Kadir, 2013). It is 
estimated that one-third of the humanity has this parasitic infection (Montoya 
and Liesenfeld, 2004; Hammond-Aryee et al., 2014). In Africa, 50% to 70% 
of the populations are infected. The seroprevalence varied widely in different 
regions of the world according to sanitation level of the population, dietary 
habits, contacts with cats or contaminated soil and climatic zones. It has been 
reported that the prevalence is higher (> 60%) in humid and forest areas, and 
less than 50% in dry or desert areas (Millogo et al, 2000 ; Studeničová et al. 
2006 ; Dubey et al., 2012; Linguissi 2012; Pangui et al., 2013).  
In Togo, the seroprevalence is estimated between 60% and 80% 
(Agbo et al., 1991; Grunitzky et al., 1995, Balogou et al. 2007). Despite the 
high rate of the toxoplasmosis in Togo, recent data are not available. The aim 
of this study was to determine the prevalence of Toxoplasma gondii infection 
in the population for the effective management of the groups that were 
exposed to high risk of contamination. 
 
Material and methods 
Studies populations and laboratory analysis on prevalence 
A prospective study from January 2012 to December 2015 concerned 
7076 patients of all ages (6158 female and 918 male) were oriented for 
serological tests for detection of Toxoplasma gondii infection.  
They were attended to National Institute of Hygiène of Togo, which 
approved the study.  
 
Collection of specimens 
Blood sample were withdrawn, from patients in the serological laboratory of 
National Institute of Hygiène (Reference center of medical analyzes of Togo), 
centrifuged (1000-2000 rpm) and sera were collected kept at 4°C.  
 
Serological tests  
Serological tests were performed by immunoenzymatic method (ELISA): 
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-for qualitative detection of anti-Toxoplasma gondii IgM antibodies using 
Platelia ™ Toxo IgM : ref 72841 (BIO-RAD, Marnes la Coquette, France); 
-for quantitative determination of anti-Toxoplasma gondii IgG antibodies 
using Platelia ™ Toxo IgG: ref 72840 (BIO-RAD, Marnes la Coquette, 
France). 
 
Information about patients: 
For this prospective study, a paper has been established for each patient from 
the registers of the laboratory, concerning the : age, sex, profession, level of 
education, living area, requesting service of the analysis, and tests results. 
 
A survey on the risk factors 
Epidemiological investigation on the risk factors to determine the 
sources of contamination was performed in the residential areas of the patients. 
Houses were randomly selected and a total of 300 were visited. The inhabitants 
were subjected to a structured survey and the questions were about the 
presence of cats or other animals (dog, mouse ..) in the house, culinary habits, 
sources of drinking water, food, knowledge and pathologies related to 
toxoplasmosis. 
 
Animals and fecal sample 
After the interrogation of the subjects, excreta of the cats were 
collected in the houses. A total of 450 cats (Felis catus) were identified during 
the study and 200 excreta samples were collected in plastic bags and stored at 
4°C. The excreta samples were analyzed by coproscopy method after 
enrichment with Willis liquid (saturated solution of NaCl: density 1.2), by 
waterline technique. The identification of Toxoplasma gondii oocysts was 
performed after optical microscope (x10, x40) observation, using reference 
manual of the laboratory of the National Direction of Livestock of Togo. 
 
Statistical methods 
Data analysis was performed using GraphPad 6.1 software. 
Quantitative results were expressed by mean±standard deviation and in 
percentage. The different groups were compared by Student test. The 
correlation coefficients were determined using Pearson test. The frequencies 
were calculated according to the formulas: 
 
All subjects = 100 X (Number of Women + Men considered) / Total population 
(Women + Men) 
Women = 100 X (Number of Women Considered) / Total Women Population 
Men = 100 X (Number of men considered) / Total population of men 
The results were considered significant for p <0.05). 
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The prevalence (P) has been calculated according to the formula:  
P = n/N * 100; (n= number of positives samples and  N = total number of 
tested samples) 
 
Results 
The study population characteristics 
The sex ratio was 0.15 in favor of women (87.30%). The mean age 
was 32.61 ± 6.8 years old (males 34.07±10.55 years old; females 32.39±6.0 
years old). The age groups of 31-45 years old and 16-30 years old were the 
most represented respectively 62.4% and 34.6% of the studied subjects 
(figure 1). 
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Figure1: Repartition of the subjects according to age and sex. 
 
Seroprevalence of IgG and IgM antibodies according to the age 
Considering the age group and its relation with the distribution of 
seropositive Toxoplasma gondii antibodies (figures 2a and 2b), we found that 
the prevalence of IgG seropositivity was high (> 45%) in all age groups. The 
age group of 46-60 years old had the highest percentage (67.8%) of positive 
results, followed by the age group of 16-30 years old (57.8%) and 31-45 years 
old (55.4%).  
For IgM, the highest seropositivity rate of Toxoplasma gondii 
antibodies was 5.74%, in the age group of 46-60 years old, followed by 2.85% 
and 2.23% in the age groups 31-45 years old and 16-30 years old respectively. 
However, it is a lack of IgM in the age group of 0-15 years old and 61-75 years 
old. A positive correlation was observed between the age and the prevalence 
of IgG (R = 0.68) and IgM (R = 0.97) in male. In female, the correlation was 
positive for IgM (R = 0.99). 
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Figure 2a: Seroprevalence of IgG antibodies 
according to the age and sex 
Figure 2b: Seroprevalence of IgM antibodies 
according to the age and sex 
 
Toxoplasmosis serology in studied population 
Table 1 reveals seroprevalence of toxoplasmosis in 7076 subjects 
included in the study, 4223 (59.7%) were seropositive for Toxoplasma gondii 
antibodies IgG and 190 (2.69%) were positive for Toxoplasma gondii 
antibodies IgM. The frequency of anti-toxoplasmosis IgG was significantly 
higher in the males (67.0% vs. 58.6%, p <0.0001). The rate of anti-
toxoplasmosis IgM was significantly higher in the female (2.81% vs. 1.85%, 
p <0.01). In this study, we observed 4067 (57.49%) immunized subjects; 
females 56.35% (3469/6158) and males 65.14% (598/918). 
Table 1. Toxoplasmosis serology according to sex 
Antibodies profil Female 
(n=6158) 
Male (n=918)  Alls (7076)  
 Number (%) Number (%) Number (%) 
IgM positive 173 (2,81) 17 (1,85) 190 (2,69) 
IgG positive 3608 (58,61) 615 (66,99) 4223 (59,7) 
IgM positive/IgG negative or IgM 
positive/IgG positive (Recent infection or 
seroconversion) 
46 (0,75) 0 (0) 46 (0,65) 
IgM negative/IgG positive (immunized) 3469 (56,35) 598 (65,14) 4067 (57,49) 
IgM negative /IgG negative(no immunized) 2516 (40,87 303 (33,01 2819 (39,85) 
 
Results of the survey on the risk factors 
The Analysis of the data collected during the survey revealed that: 
according to educational status, 88.2% of the subjects has school education 
(32.30% for primary level, 45.4% for secondary level and 10.5% for high 
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school level). In the study population, 12.2% had a knowledge of 
toxoplasmosis.  
According to their occupation, 96.5% of the subjects were often 
employees, traders or housewives and 3.5% were women farmers.  
Concerning the feed habits, regarding dietary habits, the survey data 
revealed that 80.5% of subjects consume raw garden products, 65.4% non-
potable water and 8.3% undercooked meat. 
 
Result of fecal samples analysis 
The microscopic observation of the fecal samples of the cats revealed 
that 20.5% of them excreted Toxoplasma gondii oocysts. 
 
Discussion 
The aim of this prospective study was to determine the seroprevalence 
of toxoplasmosis in the Togolese population. The high rates of subjects in the 
age group of 16 to 45 years old, representing 97%, confirm the demographic 
characteristics of developing countries, as Togo, where the majority of the 
populations is under 40 years old (POPIN).  
We found that the seroprevalence for IgG antibodies was 59.7% and 
the one for IgM was 2.7%. The significant high prevalence in men for IgG, (p 
<0.0001) has already been reported in other studies (Coelho et al., 2003). Anti-
toxoplasmosis IgG and IgM antibodies, are serological markers of 
Toxoplasma gondii infection and are synthesized during primary infection 
(Pinard et al., 2003; Dubey, 2008; Dubey and Jones, 2008; Hamad and Kadir, 
2013; Hammond-Aryee et al., 2014). Indeed, by the action of T lymphocytes 
and cytokines, especially IFN-γ, parasites encyst in tissues with a weak 
immune response (brain, muscle, eyes). The antibodies IgM, IgE, IgA were 
produced during the acute phase of the infection of Toxoplasma gondii. The 
anti-toxoplasmosis IgG production during the chronic phase providing 
lifelong protection (Kaneko et al., 2004; Couper et al., 2005; Montoya and 
Remington, 2008; Dubey et al., 2012). IgM is involved in immune responses 
by stopping the entry of the parasites into the cells and its intracellular 
replication (Kaneko et al., 2004; Couper et al., 2005). Therefore, in the 
immunized women the risk of reactivation of the cysts is reduced. However, 
in non-immunized women, the risk of infection increases with the age of 
pregnancy, and the fetus malformations associated with congenital 
toxoplasmosis increase when the infection occurs earlier in pregnancy. 
Toxoplasmosis contracted during the first trimester of pregnancy is 
responsible for spontaneous abortions, stillbirths, premature births and multi-
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visceral lesions (Pinard et al., 2003; Dubey and Jones, 2008; Montoya and 
Remington, 2008). For this reason, the 40.87% of non-immunized women in 
this study have a high risk of contamination (Avelino et al., 2004; Hammond-
Aryee et al., 2014). This explains why the screening of toxoplasmosis is a part 
of health tests advised, but not mandatory in the assessment of pregnancy in 
many African countries as Togo. In developed countries pregnant women 
benefit from a special monitoring where Toxoplasma gondii serology is one 
of the examinations required in early pregnancy (Pinard et al., 2003; Adou-
Bryn et al., 2004; Lopes-Mori et al, 2011; Hamad and Kadir, 2013; Koffi et 
al., 2015). 
In this study, the significant positive correlation, between age and 
prevalence of IgG (R = 0.68) in men and IgM (R = 0.99) in men and women, 
is explained by the increasing of the risks of infection according to the age and 
the persistence of infection during the life of patients. This observation is 
confirmed by the increasing of the seroprevalence from 45% for age group of 
1-15 years old to 67.8% for age group of 46-60 years old (Garcia et al., 1999; 
Cantos et al., 2000). 37.5% 
Former studies have shown that seroprevalence varies according to 
climatic, geographical and socio-economic conditions. The prevalences found 
in this study are lower than the one found in Central Europe: Slovakia and 
Czech Republic with 24.2% and 31.1% respectively (Svobodova et al., 1998; 
Studeničová et al. 2006), in Irak with 37.5% (Hamad and Kadir, 2013). In 
France the prevalence was 43.8% (Berger et al., 2009) and in Scotland it was 
27% (William et al., 1981). 
In West Africa, a decrease of the prevalence of toxoplasmosis was 
observed from Senegal with 40.2% (Faye et al., 1998), Mali, 27% (Dinkorma 
et al., 2013) to Mauritania, 14.3% (Monjour et al., 1983). The seroprevalence 
of 59.7% of this study is similar to those observed in Benin, 53.6% (Rodier et 
al., 1995), in Burkina, 57.8% (Millogo et al., 2000; Linguissi et al., 2012), in 
Ivory Coast, 58.7% (Koffi et al., 2015). It is lower than the one observed in 
Nigeria, 75.4% (Onadeko et al., 1996) and Ghana, 92.5% (Ayi et al., 2009). 
In Central and Eastern Africa the prevalence is above 50% (Bisvigou et al., 
2009; Pangui et al., 2013; Yobi et al., 2014). 
The seroprevalence of anti-toxoplasma antibodies found in this study 
is in correlation with the results of previous works in Togo. Comparing these 
results with the studies done 40 years ago in Togo, we observed no variation 
in seroprevalences (53% to 80%) in both sexes of all healthy and pregnant 
women (Agbo et al., 1991; Balogou et al., 2007; Apetse et al., 2015). These 
results could be explained by the fact that for decades, hygiene and dietary 
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habits, food preservation quality have not changed to prevent the 
contamination by Toxoplasma gondii which infection remains a public health 
problem in Togo. This confirms our results of the survey on the risks factors 
of the contamination by Toxopalma gondii that revealed the rate of 80.5% of 
subjects that consume raw fruits and vegetables, 65.4% use non-potable water, 
8.3% eat undercooked meat. In addition, 65% of the subjects have the contact 
with cats that 20.5% of them excreted Toxoplasma gondii oocysts. 
The lack of public health schemes to manage the spread of this 
pathogen places African populations at risk of ongoing and possibly increasing 
incidence and prevalence, as well as a corresponding increase in mortality and 
morbidity due to toxoplasmosis (Koffi et al., 2015, Soumana et al., 2016). 
 
Conclusion 
The results of this study revealed that the seroprevalence of 
toxoplasmosis remains high in the Togolese population. The data observed in 
this study should allow the country’s health authorities to establish 
sensitization and prevention programs for all age group of the population to 
explain how to avoid contamination by the food, water and soil. In the houses, 
the presence of cats (definitive hosts of Toxoplasma gondii) untreated by 
veterinarians is a permanent danger of reinfection by the inhabitants. For the 
mainly female population, the program should focus on the risks of fetal 
diseases and embryopathies related to Toxoplasma gondii infection during 
pregnancy. An effort should be made to make serological tests available for 
early detection of infection. Women of childbearing age who are not 
immunized against Toxoplasma gondii represent a group of high risk of 
contamination. The high proportion of subjects aged 15-45 years old, the most 
active and most affected by toxoplasmosis, constitutes a serious danger for the 
socio-economic development of the country. 
In addition, 65% of the subjects have the contact with cats that 20.5% 
of them excreted Toxoplasma gondii oocysts. 
 
Acknowledgments: The authors thank the staff of the National Institute of 
Hygiene for their technical support and their collaboration. 
 
Conflict of interests 
The authors have no conflicts of interest.  
 
Ethical considerations 
Ethical consideration has been completely observed by the authors. 
European Scientific Journal November 2018 edition Vol.14, No.33 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
65 
References: 
1. A'aiz, N.N., Sultan, B.A., Al-Fatlawi, S.M., Mahmood, A.A. (2014). 
Association between toxoplasma gondii infection in women and the 
presence of cardiolipin and phospholipid antibodies. European 
Scientific Journal, SPECIAL/edition Vol.3; 190-193.  
2. Adou-Bryn, K.D., Ouhon, J., Nemer, J., Yapo, C.G., Assoumou, A. 
(2004). Enquête sérologique de la toxoplasmose acquise chez les 
femmes en âge de procréer à Yopougon (Abidjan, Côte d'Ivoire. 
Bulletin de la Société de Pathologie Exotique, 97(5):345-348. 
3. Angel, S.O., Figueras, M.J., Alomar, M.L., Echeverria, P.C., Deng B. 
(2014).Toxoplasma gondii Hsp90: potential roles in essential cellular 
processes of the parasite. Parasitology; 141(9) : 1138–1147. 
https://www.cambridge.org/core/journals/parasitology/article/toxopla
sma-gondii-hsp90-potential-roles-in-essential-cellular-processes-of-
the-parasite/FEA49F3900F342B278F70683F7A43CB9  
4. Agbo, K., David, M., Amavi-Tete, T., Deniau, M. (1991). Contribution 
au diagnostic de la toxoplasmose au CHU de Lomé. Bulletin de la 
Société de Pathologie Exotique, 84, 659-664. 
5. Apetse K,Niobe D, Kombate D, Kumako V, Guinhouya K, Assogba 
K, Balogou A, Grunitzky E. opportunistic infections of HIV/AIDS in 
a neurological unit in Togo. African Journal of Neurological Sciences 
2015; 33(2): 34-40. 
6. Avelino, M.M., Campos, D.J., Parada, J.B., Castro, A.M. (2004). Risk 
factors for Toxoplasma gondii infection in women of childbearing age. 
The Brazilian Journal of Infectious Diseases, 8(2):164–174.  
7. Ayi, I., Edu, S.A., Apea-Kubi, K.A., Boamah, D., Bosompem, K.M., 
Edoh, D. (2009). Sero-Epidemiology of Toxoplasmosis Amongst 
Pregnant Women in the Greater Accra Region of Ghana. Ghana 
Medical Journal, 43(3): 107-114. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810244/pdf/GMJ43
03-0107.pdf 
8. Balogou, A., Volley, K., Belo, M., Amouzou, M., Apetse, K., 
Kombate, D., Grunitzky, E. (2007). Mortalité des patients VIH positifs 
dans le service de Neurologie du CHU-Campus de Lomé-Togo. 
African Journal of Neurological Sciences, 26: 95-101. 
9. Bamba S., Some, A., Chemla, C., Geers R., Guiguemde T.R., Villena, 
I. (2012). Analyse sérologique de la toxoplasmose pergravidique: 
évaluation des risques et perspectives du dépistage prénatal au centre 
hospitalier universitaire de Bobo Dioulasso au Burkina Faso Pan 
African Medical Journal, 1937-8688  
[http://www.panafrican-med-journal.com/content/article/12/43/full/] 
10. Berger, F., Goulet, V., Le Strat, Y., Desenclos, J.C. (2009). 
European Scientific Journal November 2018 edition Vol.14, No.33 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
66 
Toxoplasmosis among pregnant women in France: risk factors and 
change of prevalence between 1995and 2003. Revue Epidémiologique 
de Santé Publique, 57(4):241-248. 
https://doi.org/10.1016/j.respe.2009.03.006 
11. Bisvigou, U., Mickoto, B., Ngoubangoye, B., Tsonga, S.M., Akue, 
J.P., Nkoghe, D. (2009). Séroprévalence de la toxoplasmose dans une 
population rurale du Sud-Est du Gabon. Parasite, 16(3), 240-242. 
https://www.parasitejournal.org/articles/parasite/pdf/2009/03/parasite
2009163p240.pdf 
12. Cantos, G.A., Prando, M.D., Siqueira, M.V., Teixeira, R.M. (2000). 
Toxoplasmosis: occurrence of antibodies anti-Toxoplasma gondii and 
diagnosis. Revue Association Medical of Brasilia, 46(4):335–341. 
www.scielo.br/pdf/%0D/ramb/v46n4/3667.pdf 
13. Coelho, R.A., Kobayashi, M., Carvalho Jr, L.B. (2003). Prevalence of 
IgG antibodies specific to Toxoplasma gondii among blood donors in 
Recife, Northeast Brazil. Review of Institute of Medicine Tropical o f  
Sao Paulo, 45 (4):229–31. 
14. Couper, K.N., Roberts, C.W., Brombacher, F., Alexander, J., Johnson, 
L. (2005). Toxoplasma gondii-specific immunoglobulin M limits 
parasite dissemination by preventing host cell invasion. Infection and 
Immunity, 73(12), 8060-8068. 
http://iai.asm.org/content/73/12/8060.long# 
15. Dégbé M., Tété–Bénissan, A., Maman, H., Kulo, A., Batawui, B., 
Aklikokou, K., Gbeassor, M. (2018). Epidémiologie de la 
toxoplasmose au Togo : facteurs de risque dans la capitale et ses 
agglomérations. International. Journal of Biological and Chemical 
Science, 12 (1) : 479-490.  
16. Dinkorma, T. O., Djimdé A.A., Diallo N., Doumbo, O.K. and Roos, 
D.S. (2013). Toxoplasma gondii Seroprevalence in Mali. The Journal 
of Parasitology, 99(2) : 371-374. 
https://www.jstor.org/stable/41982005 
17. Dubey, J.P. (2008). The history of Toxoplasma gondii—the first 100 
years. Journal of Eukaryotic Microbiology, 55(6): 467-475.  
http://onlinelibrary.wiley.com/doi/10.1111/j.1550-
7408.2008.00345.x/pdf 
18. Dubey, J.P., Jones, J.L. (2008). Toxoplasma gondii infection in 
humans and animals in the United States. International journal for 
parasitology, 38(11), 1257-
1278.http://www.sciencedirect.com/science/article/pii/S00207519080
01100?via%3Dihub 
19. Dubey, J.P., Lago, E.G., Gennari, S.M., Su, C., Jones, J.L. (2012) 
Toxoplasmosis in humans and animals in Brazil: high prevalence, high 
European Scientific Journal November 2018 edition Vol.14, No.33 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
67 
burden of disease, and epidemiology. Parasitology, 139(11):1375–
1424.  
20. Faye, O., Leye, A., Dieng, Y . , Richard-Lenoble, D . , Diallo, S .  
(1998). La toxoplasmose à Dakar. Sondage séroépidémiologique chez 
353 femmes en âge de procréer. Bulletin de la Société de Pathologie 
Exotique, 9 1 ,249 - 250 . 
21. Fond, G., Capdevielle, D., Macgregor, A., Attal, J., Larue, A., Brittner, 
M., Boulenger, J.P. (2012) Toxoplasma gondii: A potential role in the 
genesis of psychiatric disorders. Encephale, Elsevier Masson, 2012, 
epub ahead of print. [http://www.hal.inserm.fr/inserm-
00750381].http://www.em-consulte.com/article/785899/alertePM. 
22. Garcia, J.L., Navarro, I.T., Ogawa, L., de Oliveira, R.C., Kobilka, E. 
(1999). Seroprevalence, epidemiology and ocular evaluation of 
human toxoplasmosis in the rural zone Jauguapita (Parana) Brazil. 
Revue Panam Salud Publica, 6(3):157–63. 
https://www.ncbi.nlm.nih.gov/pubmed/10517092. 
23. Grunitzky, E.K., Balogou, A.K., Vimegnon, Y.A., Agbo, K., Sadko, 
A., Prince-David, M. (1995).Toxoplasmose cérébrale en milieu 
hospitalier à Lomé (Togo). Bulletin de la Société de Pathologie 
Exotique, 88: 22-23.  
http://ajns.paans.org/dist/data/2005Vol24No2.pdf 
24. Hamad, N.R., Kadir M.A. (2013). Prevalence and comparison between 
the efficacy of different techniques for diagnosis of Toxoplasma gondii 
among women in Erbil Province-Iraqi Kurdistan. In 1st Annual 
International Interdisciplinary Conference, AIIC 2013, 24-26 April, 
Azores, Portugal – Proceedings,  P: 901-908. 
25. Hammond-Aryee, K., Esser, M., Van Helden, P.D. (2014). 
Toxoplasma gondii seroprevalence studies on humans and animals in 
Africa. South Africa Famers Practice, 56(2):119-12. 25.  
26. Koffi, M., Konaté, I., Sokouri, D.P., Konan, T., Ahouty, B., Bosso, 
J.C. (2015). Seroepidemiology of Toxoplasmosis in Pregnant Women 
Attending Antenatal Clinics at the Center for Maternal and Child 
Health Care in Daloa in Ivory Coast. International Journal of Tropical 
Disease & Health, 6(4): 125-132. 
DOI:10.9734/IJTDH/2015/15117.http://www.journalrepository.org/
media/journals/IJTDH_19/2015/Jan/Koffi642014IJTDH15117.pdf 
27. Kaneko, Y., Takashima, Y., Xuaun, X., Igarashi, I., Nagasawa, H., 
Mikami, T., Otsuka, H. (2004). Natural IgM antibodies in sera from 
various animals but not the cat kill Toxoplasma gondii by activating 
the classical complement pathway. Parasitology, 128(02):123-129. 
https://www.ncbi.nlm.nih.gov/pubmed/15029999 
European Scientific Journal November 2018 edition Vol.14, No.33 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
68 
28. Labalette, P., Delhaes, L., Margaron, F., Fortier, B., Rouland, J.F. 
(2002). Ocular toxoplasmosis after the fifth decade. American journal 
of ophthalmology, 133(4), 506-515. 
http://www.ajo.com/article/S0002-9394(02)01324-7/pdf 
29. Linguissi, L., Nagalo, B., Bisseye, C., Kagoné, S., Sanou, M., Tao, I., 
Benao, V., Simporé, J., Koné, B. (2012), Seroprevalence of 
toxoplasmosis and rubella in pregnant women attending antenatal 
private clinic at Ouagadougou, Burkina Faso. Asian Pacific Journal of 
Tropical Medicine, 810-813. 
http://www.labiogene.org/IMG/pdf/karou_antibiotique.pdf 
30. Lopes-Mori, F.M.R., Mitsuka-Bregano, R., Capobiango, J.D., Inoue, 
I.T., Reische, E.M.V., Morimoto, H.K., et al. (2011). Programs for 
control of congenital toxoplasmosis. Revue. Association Medecine 
Brasilia, 57(5):581-586.  
31. Millogo, A., Ki-Zerbo, G., Traore, W., Sawadogo, B., Ouedraogo, I., 
Peghini, M. (2000). Sérologie toxoplasmique chez les patients infectés 
par le VIH et suspects de toxoplasmose cérébrale au centre hospitalier 
de Bobo-Dioulasso (Burkina-Faso). Bulletin de la Société de 
Pathologie Exotique, 93: 17-19. 
 http://www.pathexo.fr/documents/articles-bull/T93-1-2057.pdf 
32. Monjour, L., Niel, G., Palminteri, R., Sidatt, M., Daniel-Ribeiro, C., et 
al. (1983). An epidemiological survey of toxoplasmosis in Mauritania. 
Tropical Geog Medecine, 35:21-24.  
33. Montoya, J., Liesenfeld, O. (2004) «Toxoplasmosis». Lancet, 
363(9425):19651976.http://www.thelancet.com/journals/lancet/articl
e/PIIS0140-6736(04)16412-X/fulltext 
34. Montoya, J.G., Remington, J.S. (2008). Management of Toxoplasma 
gondii Infection during Pregnancy. Clinical Infectious Diseases, 
47:554–566. 
https://academic.oup.com/cid/article-lookup/doi/10.1086/590149 
35. Onadeko, M.O., Joynson, D.H., Payne, R.A., Francis, J. (1996). The 
prevalence of toxoplasma antibodies in pregnant Nigerian women and 
the occurrence of stillbirth and congenital malformation. African 
Journal of Medical Science, 25:331-334.  
36. Pangui, L.J., Gbati, O.B., Kamga Waladjo, A.R., Bakou, S.N.(2013). 
Point sur la toxoplasmose en Afrique de l’ouest et du centre. Revue 
Africaine de Santé et de Productions Animales,11 (S) : 29-40.  
http://www.e-ucad.sn/eismv/2016/07/02/documentation/ PDF 
37. Pinard, J.A., Leslie, N.S., Irvine, P.J. (2003). Maternal serologic 
screening for toxoplasmosis. Journal of Midwifery Womens and Health, 
48(5):308–16 [quiz 386]. 
European Scientific Journal November 2018 edition Vol.14, No.33 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
69 
38. POPIN, United Nations Population Information Network : Population 
et Développement en Afrique, OUA& CEA  
http://www.un.org/popin/icpd/conference/bkg/afrique.html [consulté 
en juillet 2018] 
39. Rodier, M.H., Berthonneau, J., Bourgoin, A., Giraudeau, G., Agius, 
G., Burucoa. (1995) Seroprevalences of Toxoplasma, malaria, rubella, 
cytomegalovirus, HIV and treponemal infections among pregnant 
women in Cotonou, Republic of Benin. Acta Tropicalis, 59(4):271-
277.  
40. Studeničová, C., Gabriela, B., Renata, H. (2006). Seroprevalence of 
Toxoplasma gondii antibodies in a healthy population from Slovakia. 
European Journal of Internal Medicine, 17: 470–473. 
https://www.researchgate.net/publication/6698116_Seroprevalence_o
f_Toxoplasma_gondii_antibodies_in_a_healthy_population_from_Sl
ovakia. 
41. Svobodova, V., Literak, I. (1998). Prevalence of IgM and IgG 
antibodies to Toxoplasma gondii in blood donors in the Czech 
Republic. European Journal of Epidemiology, 14(8):803–5. 
https://www.ncbi.nlm.nih.gov/pubmed/9928876. 
42. Uttah, E.C., Ajang, R., Ogbeche, J., Etta, H., Etim, L. (2013). 
Comparative Seroprevalence and Risk Factors of Toxoplasmosis 
among Three Subgroups in Nigeria. Journal of Natural Science 
Research, 23-29. 
http://www.iiste.org/Journals/index.php/JNSR/article/download/6891
/6997 
43. Webster, J.P. (2001). Rats, cats, people and parasites: the impact of 
latent toxoplasmosis on behaviour. Microbes and infection, 
3(12):1037-1045.Article /pii/S1286457901014599?via%3Dihu. 
44. Williams, K.A., Scott, J.M., Macfarlane, D.E., Williamson, J.M., 
Elias-Jones, T.F., Williams, H. (1981). Congenital toxoplasmosis: a 
prospective survey in the West of Scotland. Journal of Infection, 
3(3):219–29. 
45. Yobi, D., Y., Piarroux R., L’Ollivier C., Franck J, Situakibanza 
H, Muhindo H, Mitashi P, Raquel Andreia Inocêncio da Luz, Van 
Sprundel M, Boelaert M, Van Geertruyden JP, Lutumba P. (2014). 
Toxoplasmosis among pregnant women: high seroprevalence and risk 
factors in Kinshasa, Democratic Republic of Congo. Asian Pacific 
Journal of Tropical Biomedical 2014; 4(1): 69-74). 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819499/pdf/apjtb-
04-01-069.pdf 
 
  
